Molten Ventures PLC GROW

CAMBRIDGE, England, July 29, 2026--Qureight, an end-to-end imaging company that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung and heart disease, today announced it has raised $20 million in a Series B financing, led by Molten Ventures. Existing investors Hargreave Hale AIM VCT, XTX Ventures, Guinness Ventures, Meltwind, and Ascension also participated in the round. The new capital will support expansion of the Company’s 3D deep learning imagin

The latest update on Molten Ventures centres on a revised fair value price target, moving from £6.73 to £7.69 in the newest round of modelling. Analysts link this higher central estimate to refreshed assumptions and a more detailed view of how Molten Ventures’ portfolio risk and longer term growth profile are captured in their work, while still flagging both supports and pressure points around the target. Read on to see what is driving the evolving narrative and how to keep track of future...

Molten Ventures (LON:GROW) said portfolio fair value growth accelerated during the year, while management pointed to defense, space, artificial intelligence and European technology sovereignty as major structural themes shaping its investment strategy. Chief Executive Ben Wilkinson told investors t

LONDON, June 02, 2026--IMU Biosciences (‘IMU or the ‘Company’), a biotechnology company decoding the immune system to pioneer a paradigm shift in how we understand, diagnose and treat disease, has successfully brought its Series A to over $53 million (£40 million) in an oversubscribed financing round, co-led by IQ Capital and Molten Ventures, and supported by The British Business Bank and Meltwind alongside existing investors.

The latest Street update keeps the blended price target for Molten Ventures anchored at £5.75, with Fair Value in the model steady at £6.34. That stability reflects a view that upcoming net asset value catalysts and portfolio execution could be important for how closely the share price tracks that £5.75 target. As you read on, you will see how this evolving narrative around price targets and net asset value highlights what to watch next in the story. Analyst Price Targets don't always capture...

Manna is leaning into a no-frills, ultra-low-cost strategy as regulators open the door to scaled autonomous delivery.

Molten Ventures is back in focus as analysts revisit their narrative around a revised £575 price target and the recent £35 uplift. That new level is being linked directly to expectations for net asset value growth, with bullish voices pointing to specific portfolio catalysts while more cautious views highlight execution risk and the tight gap to the current share price. As you read on, you will see how these competing arguments shape the evolving story around Molten Ventures and what it could...